Yasuyoshi Watanabe

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 06:02, December 21, 2018 by Kmdenmark (talk | contribs) (→‎Notable studies: added study)

Yasuyoshi Watanabe, MD, PhD, is the Director of RIKEN BDR-DAIKIN Collaboration Center at RIKEN Center for Life Science Technologies, Kobe City, Hyogo, Japan.

Dr. Watanabe is the associate editor of the journal Fatigue: Biomedicine, Health & Behavior.

IOM Committee on Diagnostic Criteria for ME/CFS[edit | edit source]

Dr Watanabe was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[1]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ https://www.nap.edu/resource/19012/MECFS_Powerpoint.pdf
  2. ↑ Tanakaa, Masaaki; Watanabe, Yasuyoshi (August 1, 2010). "A new hypothesis of chronic fatigue syndrome: Co-conditioning theory". Medical Hypotheses. 75 (2): 244–249. doi:10.1016/j.mehy.2010.02.032. ISSN 0306-9877.
  3. ↑ Mizuno, K.; Tanaka, M.; Tanabe, H.C.; Joudoi, T.; Kawatani, J.; Shigihara, Y.; Tomoda, A.; Miike, T.; Imai-Matsumura, K.; Sadato, N.; Watanabe, Y. (2015), "Less efficient and costly processes of frontal cortex in childhood chronic fatigue syndrome", NeuroImage : Clinical, 2015 (9): 355–368, doi:10.1016/j.nicl.2015.09.001, PMID 26594619
  4. ↑ Nakatomi, Yasuhito; Mizuno, Kei; Ishii, Akira; et al. (March 24, 2014), "Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study", Journal of Nuclear Medicine, 2014 Jun, 55(6): 945-50, doi:10.2967/jnumed.113.131045, PMID 24665088
  5. ↑ Mizuno, K., Tanaka, M., Tanabe, H. C., Joudoi, T., Kawatani, J., Shigihara, Y., … Watanabe, Y. (2015). Less efficient and costly processes of frontal cortex in childhood chronic fatigue syndrome. NeuroImage : Clinical, 9, 355–368. http://doi.org/10.1016/j.nicl.2015.09.001
  6. ↑ FTanaka, M., Tajima, S., Mizuno, K., Ishii, A., Konishi, Y., Miike, T., & Watanabe, Y. (2015). Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder. The Journal of Physiological Sciences, 65(6), 483–498. http://doi.org/10.1007/s12576-015-0399-y
  7. ↑ Tanaka, M., Ishii, A., & Watanabe, Y. (2016). Neural effect of physical fatigue on mental fatigue: a magnetoencephalography study. Fatigue: Biomedicine, Health & Behavior, 4 (2), 104-114. doi:10.1080/21641846.2016.1167471
  8. ↑ Tanaka, Masaaki, Akira Ishii, and Yasuyoshi Watanabe. (2016). Roles of the right dorsolateral prefrontal cortex during physical fatigue: a magnetoencephalographic study. Fatigue: Biomedicine, Health & Behavior 4 (3):146-157. doi:10.1080/21641846.2016.1175179
  9. ↑ Fukuda, S; Nojima, J; Kajimoto, O; Yamaguti, K; Nakatomi, Y; Kuratsune, H; Watanabe, Y (April 29, 2016), "Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome", BioFactors (Oxford, England), doi:10.1002/biof.1293, PMID 27125909
  10. ↑ Yamano, Emi; Sugimoto, Masahiro; Hirayama, Akiyoshi; Kume, Satoshi; Yamato, Masanori; Jin, Guanghua; Tajima, Seiki; Goda, Nobuhito; Iwai, Kazuhiro; Fukuda, Sanae; Yamaguti, Kouzi; Kuratsune, Hirohiko; Soga, Tomoyoshi; Watanabe, Yasuyoshi; Kataoka, Yosky (2016), "Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles", Scientific Reports, 6 (34990), doi:10.1038/srep34990, PMID 27725700
  11. ↑ Nakatomi, Y; Kuratsune, H; Watanabe, Y (2018), "Neuroinflammation in the Brain of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", Brain Nerve, 70 (1): 19-25, doi:10.11477/mf.1416200945, PMID 29348371

National Academy of Medicine (NAM) - An American non-profit, non-governmental organization which provides expert advice to governmental agencies on issues relating to biomedical science, medicine and health. Formerly known as the Institute of Medicine (IOM).

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

cognition Thought processes, including attention, reasoning, and memory.

physiological Concerning living organisms, such as cells or the human body.  Physio logical (as in physio) is not to be confused with psych ological (emotional stress).

Retrieved from "https://me-pedia.org/w/index.php?title=Yasuyoshi_Watanabe&oldid=45350"